ConductScience.org, home

Paper23102497

Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients.

Aparicio T and 13 others. Dig Liver Dis, 2013. Cited by 32 papers, by iCite.

Cite this record

ConductScience Library. Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients. Papers, record 23102497. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/23102497

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Deficient mismatch repair phenotype is a prognostic factor for colorectal cancer in elderly patients.
PubMed
Journal
Dig Liver Dis
PubMed
Year
2013
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
32
iCite
Relative citation ratio, by iCite
0.86
iCite
Revised in PubMed
2022-03-10
PubMed

Authors14

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aparicio TThomas
2Schischmanoff OOlivier
3Poupardin CCecile
4Soufir NNadem
5Angelakov CCeline
6Barrat CChristophe
7Levy VVincent
8Choudat LLaurence
9Cucherousset JJoel
10Boubaya MMarouane
11Lagorce CChristine
12Guetz GDGaetan Des
13Wind PPhilippe
14Benamouzig RRobert

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
AdenocarcinomaMajor topic
Colorectal NeoplasmsMajor topic
DNA Mismatch RepairMajor topic
Microsatellite InstabilityMajor topic
Age Factors
Aged
Aged, 80 and over
DNA Methylation
Disease-Free Survival
Female
Humans
Male
Phenotype
Prognosis
Retrospective Studies

Source PubMed

Download CSV of topics

Cited by16

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 32 citations.

PMIDTitleJournalYearIn PapersSource
40141143Polyphenol Intake in Elderly Patients: A Novel Approach to Counteract Colorectal Cancer Risk?Int J Mol Sci2025https://conductscience.org/library/papers/40141143PubMed
39847281Risk of Lymph Node Metastasis in T2 Colon Cancer: A Nationwide Population-Based Cohort Study.Ann Surg Oncol2025https://conductscience.org/library/papers/39847281PubMed
39640494Aging and cancer: Clinical role of tumor markers in the geriatric population (Review).Med Int (Lond)2024https://conductscience.org/library/papers/39640494PubMed
38948479Navigating through novelties concerning mCRC treatment-the role of immunotherapy, chemotherapy, and targeted therapy in mCRC.Front Surg2024https://conductscience.org/library/papers/38948479PubMed
38818960Lymphatic spread patterns in young versus elderly patients with stage III colon cancer.BJS Open2024https://conductscience.org/library/papers/38818960PubMed
38547438Oxaliplatin-Based Adjuvant Chemotherapy in Older Patients With Stage III Colon Cancer: An ACCENT/IDEA Pooled Analysis of 12 Trials.J Clin Oncol2024https://conductscience.org/library/papers/38547438PubMed
37052812Guidance for Treating the Older Adults with Colorectal Cancer.Curr Treat Options Oncol2023https://conductscience.org/library/papers/37052812PubMed
34143421Management of Metastatic Colorectal Carcinoma in Older Adults: Balancing Risks and Benefits of Novel Therapies.Drugs Aging2021https://conductscience.org/library/papers/34143421PubMed
33604737Rate of dissemination and prognosis in early and advanced stage colorectal cancer based on microsatellite instability status: systematic review and meta-analysis.Int J Colorectal Dis2021https://conductscience.org/library/papers/33604737PubMed
32823998Adjuvant Chemotherapy in Elderly Colorectal Cancer Patients.Cancers (Basel)2020https://conductscience.org/library/papers/32823998PubMed
30411662Prognostic Value of Mismatch Repair Genes for Patients With Colorectal Cancer: Meta-Analysis.Technol Cancer Res Treat2018https://conductscience.org/library/papers/30411662PubMed
29713641Treatment of Elderly Patients with Colorectal Cancer.Biomed Res Int2018https://conductscience.org/library/papers/29713641PubMed
29071260Effect of Adjuvant Chemotherapy on Elderly Colorectal Cancer Patients: Lack of Evidence.Gastrointest Tumors2017https://conductscience.org/library/papers/29071260PubMed
26770629Human mutL homolog 1 expression characteristic and prognostic effect on patients with sporadic colorectal cancer.Int J Clin Exp Med2015https://conductscience.org/library/papers/26770629PubMed
25973534Combination of microsatellite instability and BRAF mutation status for subtyping colorectal cancer.Br J Cancer2015https://conductscience.org/library/papers/25973534PubMed
24196786Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study.Br J Cancer2013https://conductscience.org/library/papers/24196786PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
MLH14292PubTator's text mininghttps://conductscience.org/library/genes/4292

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/23102497

GET https://conductscience.org/api/papers/v1/23102497/authors